CAS: 99873-43-5; Droxinostat

该化合物是一种化学化合物,被归类为丙酮脱乙酰酶抑制剂,在基因表达的调控中起着重要作用,主要调查其在癌症治疗和其他异常细胞生长的疾病中的潜在治疗用途;该化合物展示了一种独特的行动机制,改变了丙酮的发炎状态,导致染色体结构和基因转录的变化;德鲁克辛诺斯特因其能诱发细胞循环阻塞和癌症细胞中的流行性硬化,使其成为肿瘤研究的感兴趣对象;此外,该物质由于对...

结构式图片

欧盟法规

ECHA物质C&L通报

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-10772971-B2
    优先权日:2017-06-22
    标 题:Methods of producing drug-carrying polymer scaffolds and protein-polymer-drug conjugates
    发明人:GURIJALA VENU REDDY; BOLLU SATYANARAYAN REDDY; LEBLANC JACQUES; LOWINGER TIMOTHY B; MCGILLICUDDY DENNIS; YIN MAO; YURKOVETSKIY ALEKSANDR V
    权利人:MERSANA THERAPEUTICS INC; MERSANA THERPEUTICS INC
    摘要:The disclosure provides methods of synthesis of polymeric scaffolds, e.g., those useful for conjugating with a protein based recognition-molecule (PBRM) to form PBRM-polymer-drug conjugates, and PBRM-polymer-drug conjugates thereof. The methods according to the disclosure allow for large-scale preparation of polymeric scaffolds having a high purity. In some embodiments, the methods according to the disclosure also allow for the preparation of scaffolds and conjugates thereof in better yield than previously used methods for preparing same. Also disclosed are methods of purifying polymeric scaffolds.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Alrouji M, Venkatesan K, Alshammari MS, Alhumaydhi FA, Shafi S, Sharaf SE, Shahwan M, Shamsi A. Repurposed drugs as histone deacetylase 8 inhibitors: Implications in cancer and neuropathological conditions. Front Pharmacol. 2024 Nov 14;15:1488585. doi: 10.3389/fphar.2024.1488585.
    2: Yao S, Deng M, Du X, Huang R, Chen Q. A Novel Hypoxia Related Marker in Blood Link to Aid Diagnosis and Therapy in Osteoarthritis. Genes (Basel). 2022 Aug 23;13(9):1501. doi: 10.3390/genes13091501.
    3: Song Z, Yang L, Hu W, Yi J, Feng F, Zhu L. Effects of histone H4 hyperacetylation on inhibiting MMP2 and MMP9 in human amniotic epithelial cells and in premature rupture of fetal membranes. Exp Ther Med. 2021 May;21(5):515. doi: 10.3892/etm.2021.9946. Epub 2021 Mar 22.

    合成参考文献


    参考文献:10.1371/journal.pone.0218897
    摘要:Miller TW, Amason JD, Garcin ED, Lamy L, Dranchak PK, Macarthur R, Braisted J, Rubin JS, Burgess TL, Farrell CL, Roberts DD, Inglese J. Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors. PLoS ONE. 2019 Jul 05;14(7):e0218897. doi: 10.1371/journal.pone.0218897.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知